Article info
Correspondence
Additional response to the correspondence: ‘Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?’ by Cantini and Bennuci
- Correspondence to Dr Marc Scherlinger, Service de Rhumatologie, Centre Hospitalier Universitaire de Bordeaux, 33000 Bordeaux, France; marc.scherlinger{at}chu-bordeaux.fr
Citation
Additional response to the correspondence: ‘Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?’ by Cantini and Bennuci
Publication history
- Received March 2, 2018
- Accepted March 5, 2018
- First published March 13, 2018.
Online issue publication
March 12, 2019
Article Versions
- Previous version (13 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.